Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery · 2024
[Stent-grafts for transjugular intrahepatic portosystemic shunt creation].
Аннотация на английскомСтатьяНазвание и аннотация: Оригинал на русском
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zatevakhin I I, Shipovskiy V N, Tsitsiashvili M Sh, Monakhov D V, Zabadaeva O B
Аннотация
OBJECTIVE: The purpose of this study was to compare clinical results of using an original combined stent construction E-Luminexx + LifeStream and a Hanarostent graft for transjugular intrahepatic portosystemic shunting (TIPS).
PATIENTS AND METHODS: We retrospectively analyzed the results of treating a total of 89 patients after a TIPS procedure using either a combined stent construction E-Luminexx + LifeStream or a Hanarostent graft. The study included 44 men and 45 women, average age 54.4±10.1 years (range 33-71). The patients were divided into two groups: Group I consisted of 50 (56.2%) patients subjected to the TIPS procedure using the stent construction E-Luminexx + LifeStream and Group II comprised 39 (43.8%) patients treated with the Hanarostent graft.
RESULTS: According to Kaplan-Meier analysis, cumulative primary patency in Group I and Group II patients at 1, 6, 24 and 48 months amounted to 93.9%, 91.8%, 81.5% and 73.1 vs 89.7, 81.8, 65,2 and 46.6%, respectively.
CONCLUSION: A comparative analysis of the short- and long-term results of TIPS created by means of the combined construction E-Luminexx + LifeStream and the Hanarostent revealed good comparable 12-month primary patency (85.3 vs 76.6%).
PATIENTS AND METHODS: We retrospectively analyzed the results of treating a total of 89 patients after a TIPS procedure using either a combined stent construction E-Luminexx + LifeStream or a Hanarostent graft. The study included 44 men and 45 women, average age 54.4±10.1 years (range 33-71). The patients were divided into two groups: Group I consisted of 50 (56.2%) patients subjected to the TIPS procedure using the stent construction E-Luminexx + LifeStream and Group II comprised 39 (43.8%) patients treated with the Hanarostent graft.
RESULTS: According to Kaplan-Meier analysis, cumulative primary patency in Group I and Group II patients at 1, 6, 24 and 48 months amounted to 93.9%, 91.8%, 81.5% and 73.1 vs 89.7, 81.8, 65,2 and 46.6%, respectively.
CONCLUSION: A comparative analysis of the short- and long-term results of TIPS created by means of the combined construction E-Luminexx + LifeStream and the Hanarostent revealed good comparable 12-month primary patency (85.3 vs 76.6%).